← Leaderboards
Gary Matthew Hunninghake
Brigham And Women'S Hospital
$13,432,772
Attributed
$22,351,146
Total exposure
6
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2.8M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$22,351,146 · 6
By mechanism
R01$21,272,656 · 3
K08$689,040 · 1
P30$275,562 · 1
F32$113,888 · 1
Top collaborators
- Benjamin Alexander Raby8 shared
- Ivan O. Rosas8 shared
- Michael H. Cho6 shared
Most similar at Brigham And Women'S Hospital
Same institution · by research overlap
- Juan Carlos Celedon$24,953,784
- Joann Elisabeth Manson$50,755,529
- Jessica A Lasky-Su$15,770,335
- Tracy Jennifer Doyle$2,364,485
- Michael H. Cho$16,257,579
Others in their field
Top investigators on “Genetic”
- Richard A Gibbs · Baylor College Of Medicine$577,061,667
- Eric S Lander · Whitehead Institute For Biomedical Res$560,806,052
- David R. Weir · University Of Michigan At Ann Arbor$322,225,557
- Richard K. Wilson · Washington University$316,685,275
- Lawrence Corey · Fred Hutchinson Cancer Center$312,182,347
- Margaret Juliana McElrath · Fred Hutchinson Cancer Center$302,429,647
Research focus
GeneticPrevalenceCohortMalignant NeoplasmsPulmonary FibrosisLungGenesInterstitialDetectionVariantMedicalPhysiologicalBaseGenetic VariantMortalityPatternPhenotypePharmacotherapyGenomicsScreeningX-Ray Computed TomographyChest Computed TomographyPositioning AttributeCicatrix
Grant awards (33)
Genetic and Genomic Characterization of the Occurrence and Progression of Interstitial Lung Abnormalities$1,542,983
R01 · FY2025 · HL · contact PI
Clinical Genetics and Screening for Pulmonary Fibrosis$1,283,458
R01 · FY2025 · HL · contact PI
Genetic and Genomic Characterization of the Occurrence and Progression of Interstitial Lung Abnormalities$1,489,128
R01 · FY2024 · HL · contact PI
Clinical Genetics and Screening for Pulmonary Fibrosis$1,320,990
R01 · FY2024 · HL · contact PI
Clinical Genetics and Screening for Pulmonary Fibrosis$1,385,234
R01 · FY2023 · HL · contact PI
Clinical Genetics and Screening for Pulmonary Fibrosis$1,452,517
R01 · FY2022 · HL · contact PI
Interstitial Lung Abnormalities: Defining the Phenotype, Causes, and Consequences.$820,729
R01 · FY2022 · HL · contact PI
Interstitial Lung Abnormalities: Defining the Phenotype, Causes, and Consequences.$866,066
R01 · FY2021 · HL · contact PI
Interstitial Lung Abnormalities: Defining the Phenotype, Causes, and Consequences.$866,907
R01 · FY2020 · HL · contact PI
Genetic and Genomic Characterization of the Occurrence and Progression of Interstitial Lung Abnormalities$800,376
R01 · FY2020 · HL · contact PI
Interstitial Lung Abnormalities: Defining the Phenotype, Causes, and Consequences.$903,043
R01 · FY2019 · HL · contact PI
Genetic and Genomic Characterization of the Occurrence and Progression of Interstitial Lung Abnormalities$843,606
R01 · FY2019 · HL · contact PI
Clinical Genetics and Screening for Pulmonary Fibrosis$763,525
R01 · FY2019 · HL
Clinical Genetics and Screening for Pulmonary Fibrosis$818,151
R01 · FY2018 · HL
Genetic and Genomic Characterization of the Occurrence and Progression of Interstitial Lung Abnormalities$669,110
R01 · FY2018 · HL · contact PI
Clinical Genetics and Screening for Pulmonary Fibrosis$876,901
R01 · FY2017 · HL
Genetic and Genomic Characterization of the Occurrence and Progression of Interstitial Lung Abnormalities$787,403
R01 · FY2017 · HL · contact PI
Interstitial Lung Abnormalities: Defining the Phenotype, Causes, and Consequences$633,175
R01 · FY2017 · HL · contact PI
Clinical Genetics and Screening for Pulmonary Fibrosis$877,331
R01 · FY2016 · HL
Interstitial Lung Abnormalities: Defining the Phenotype, Causes, and Consequences$716,703
R01 · FY2016 · HL · contact PI
Interstitial Lung Abnormalities: Defining the Phenotype, Causes, and Consequences$593,891
R01 · FY2015 · HL · contact PI
Interstitial Lung Abnormalities: Defining the Phenotype, Causes, and Consequences$542,074
R01 · FY2014 · HL · contact PI
Interstitial Lung Abnormalities: Defining the Phenotype, Causes, and Consequences$419,355
R01 · FY2013 · HL · contact PI
Fine-mapping Association Analysis of Total IgE on Chr. 20p12 in Costa Ricans$138,780
K08 · FY2012 · HL · contact PI
Fine-mapping Association Analysis of Total IgE on Chr. 20p12 in Costa Ricans$138,780
K08 · FY2011 · HL · contact PI
Fine-mapping Association Analysis of Total IgE on Chr. 20p12 in Costa Ricans$137,970
K08 · FY2010 · HL · contact PI
Fine-mapping Association Analysis of Total IgE on Chr. 20p12 in Costa Ricans$137,160
K08 · FY2009 · HL · contact PI
Fine-mapping Association Analysis of Total IgE on Chr. 20p12 in Costa Ricans$136,350
K08 · FY2008 · HL · contact PI
The Genetic Epidemiology of Asthma in Costa Rica$58,036
F32 · FY2007 · HL · contact PI
Facility D: Molecular Immunology and Cell Biology$91,854
P30 · FY2006 · ES · contact PI
The Genetic Epidemiology of Asthma in Costa Rica$55,852
F32 · FY2006 · HL · contact PI
Facility D: Molecular Immunology and Cell Biology$91,854
P30 · FY2005 · ES
Facility D: Molecular Immunology and Cell Biology$91,854
P30 · FY2004 · ES